Botulinum toxin

Ipsen Delivers a Strong Sales Performance in the First Quarter Of 2022

Retrieved on: 
Wednesday, April 27, 2022

North America sales comprised 32.9% of total sales in the quarter (Q1 2021: 33.8%).

Key Points: 
  • North America sales comprised 32.9% of total sales in the quarter (Q1 2021: 33.8%).
  • Sales in Europe comprised 44.3% of total sales in the quarter (Q1 2021: 47.2%).
  • Sales reached 156.9m in the quarter, an increase of 35.4%6, driven by solid volumes growth in Oncology and Neuroscience.
  • Rest of the World sales comprised 22.8% of total sales in the quarter (Q1 2021: 18.9%).

Kaskela Law LLC Announces Stockholder Investigation of Evolus, Inc. (EOLS) and Encourages Long-Term EOLS Stockholders to Contact the Firm

Retrieved on: 
Saturday, April 16, 2022

PHILADELPHIA, April 16, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS) on behalf of the Companys long-term shareholders.

Key Points: 
  • PHILADELPHIA, April 16, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS) on behalf of the Companys long-term shareholders.
  • Evolus stockholders who purchased or acquired shares of the Companys common stock prior to May 20, 2019 are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.)
  • at (484) 229 0750, or by email( [email protected] )oronline at https://kaskelalaw.com/cases/evolus-inc/ , for additional information about this investigation and their legal rights and options.
  • Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation.

Medical Weight Loss and Beauty Helps Californians Lose Weight and Feel Confident in Their Own Skin

Retrieved on: 
Wednesday, April 13, 2022

Medical Weight Loss and Beauty was founded by Dr. James Kojian M.D., a world-renowned expert in safe and effective anti-aging and weight loss treatments.

Key Points: 
  • Medical Weight Loss and Beauty was founded by Dr. James Kojian M.D., a world-renowned expert in safe and effective anti-aging and weight loss treatments.
  • As a weight loss clinic and medical spa rolled into one, Medical Weight Loss and Beauty has helped countless Californians achieve their weight loss goals and feel more confident in their own skin.
  • So, if youre looking for a fantastic phentermine weight loss service Pasadena , look no further than the Medical Weight Loss and Beauty clinic.
  • Medical Weight Loss and Beauty is a medically assisted weight loss clinic conveniently located in Pasadena, CA.

DelNova to Advance ReViVox™, A Groundbreaking Rescue Drug to Reverse Botulinum Toxin Neuromodulator Complications

Retrieved on: 
Friday, April 1, 2022

SAN DIEGO and CHICAGO, April 1, 2022 /PRNewswire/ -- DelNova, a biopharmaceutical company targeting unmet medical needs, by developing clinically validated molecules linked to advances in drug delivery, announced today that the company is making substantive progress in developing the first ever product to reverse complications arising from administration of botulinum toxin neuromodulators, such as BOTOX®, Dysport®, XEOMIN®, and Jeuveau®. According to the syndicated research firm Fortune Business Insights, the worldwide market for botulinum toxins worldwide is nearly $5 billion and growing steadily; however, potential side effects currently hinder industry growth [https://www.fortunebusinessinsights.com/industry-reports/botulinum-toxin...

Key Points: 
  • DelNova announces advances in the development of the First ever product to reverse complications arising from botulinum toxins, such as BOTOX, Dysport, XEOMIN, and Jeuveau, US patent and launch of STARTENGINE equity crowdfunding.
  • Dr. Yoelin is based in Orange County, CA, and has 20 years of minimally invasive medical aesthetics experience.
  • DelNova, Inc. is a privately held biopharmaceutical company developing innovative therapeutics using clinically validated molecules linked to advances in drug delivery to solve unmet medical needs.
  • The company's lead clinical candidate, ReViVox, is designed for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies, specifically botulinum toxins type A (e.g., Botox).For more informationplease visit https://delnova.net/about-delnova/

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Evolus, Inc. (NASDAQ: EOLS) and Encourages Long-Term EOLS Shareholders to Contact the Firm

Retrieved on: 
Tuesday, March 29, 2022

PHILADELPHIA, March 29, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS) on behalf of the Companys long-term shareholders.

Key Points: 
  • PHILADELPHIA, March 29, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS) on behalf of the Companys long-term shareholders.
  • According to the complaint, during that time period Evolus made a series of false and misleading statements about Jeuveau, the Companys BOTOX product.
  • Evolus stockholders who purchased or acquired shares of the Companys common stock prior to May 20, 2019 are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.)
  • Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation.

Lakewood Ranch Announces New Waterside Place Tenants Opening This Year

Retrieved on: 
Thursday, March 31, 2022

LAKEWOOD RANCH, Fla., March 31, 2022 /PRNewswire/ -- Lakewood Ranch, the nation's best-selling master-planned community for all ages, has announced numerous new tenants for its 36-acre retail, dining and entertainment destination, Waterside Place.

Key Points: 
  • LAKEWOOD RANCH, Fla., March 31, 2022 /PRNewswire/ -- Lakewood Ranch, the nation's best-selling master-planned community for all ages, has announced numerous new tenants for its 36-acre retail, dining and entertainment destination, Waterside Place.
  • Shore Rejuvenation Day Spa and Modish Salon will offer Waterside Place visitors the opportunity to relax and feel refreshed with luxury spa treatments and on-trend hairstyles.
  • In anticipation of the Kingfisher Estates opening at Lakewood Ranch, John Cannon Homes will be displaying room vignettes with custom high-end finishes in its retail space at Waterside Place.
  • "We're thrilled Waterside Place is officially open and visitors can finally experience our curated, eclectic mix of tenants," said Kirk Boylston, president of Lakewood Ranch Commercial.

Emergent BioSolutions Provides Corporate Governance Update

Retrieved on: 
Wednesday, March 23, 2022

Zsolt Harsanyi, Ph.D., an independent director at Emergent since 2004, has been appointed as chairman of the board.

Key Points: 
  • Zsolt Harsanyi, Ph.D., an independent director at Emergent since 2004, has been appointed as chairman of the board.
  • He will serve as a member of the boards nominating and corporate governance and strategic operations committees.
  • Ronald B. Richard, lead independent director at Emergent, stated, We are pleased to welcome Keith Katkin to the board.
  • Dr. Zsolt Harsanyi has served as a director of Emergent BioSolutions since August 2004.

Merz Aesthetics to Showcase New Data at the 20th Aesthetics & Anti-Aging Medicine World Congress 2022

Retrieved on: 
Thursday, March 31, 2022

Merz Aesthetics is organizing an expert program led by esteemed medical aesthetic experts and presenting new data throughout the course of the meeting.

Key Points: 
  • Merz Aesthetics is organizing an expert program led by esteemed medical aesthetic experts and presenting new data throughout the course of the meeting.
  • Merz Aesthetics is organizing expert-led keynote sessions to be held on Thursday, 31 March Friday, 01 April (via registration only).
  • Merz Aesthetics is part of Merz Group, a family-owned business founded in 1908 and based in Frankfurt, Germany.
  • MERZ, MERZ AESTHETICS and the MERZ logo are registered trademarks of Merz Pharma GmbH & Co. KGaA.

ALLERGAN AESTHETICS BRINGS DATA, INNOVATION & INDUSTRY EXPERTISE TO THE 2022 AESTHETIC AND ANTI-AGING MEDICINE WORLD CONGRESS (AMWC)

Retrieved on: 
Tuesday, March 29, 2022

IRVINE, Calif., March 29, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, will join industry colleagues and healthcare providers from around the globe for the 20th edition of AMWC in Monaco, France.

Key Points: 
  • The hybrid meeting will be held at Grimaldi Forum, Monaco March 31, 2022 April 2, 2022.
  • Allergan Aesthetics will provide a range of in-person and virtual training packages to support appropriate medical professionals who wish to offer HArmonyCa with Lidocaine to their patients across Europe and in select EEMEA countries.
  • Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
  • AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

ALLERGAN AESTHETICS BRINGS DATA, INNOVATION & INDUSTRY EXPERTISE TO THE 2022 AESTHETIC AND ANTI-AGING MEDICINE WORLD CONGRESS (AMWC)

Retrieved on: 
Tuesday, March 29, 2022

IRVINE, Calif., March 29, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, will join industry colleagues and healthcare providers from around the globe for the 20th edition of AMWC in Monaco, France.

Key Points: 
  • The hybrid meeting will be held at Grimaldi Forum, Monaco March 31, 2022 April 2, 2022.
  • Allergan Aesthetics will provide a range of in-person and virtual training packages to support appropriate medical professionals who wish to offer HArmonyCa with Lidocaine to their patients across Europe and in select EEMEA countries.
  • Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
  • AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.